Tetanus antibody protection among HIV-infected US-born patients and immigrants

[1] Pascual FB(2003)Tetanus surveillance — United States, 1998—2000 MMWR Surveill Summ 52 1-8

[2] McGinley EL(2003)Recommended childhood immunization schedule—United States, 2003 MMWR Morb Mortal Wkly Rep 52 Q1-Q4

[3] Zanardi LR(2006)Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel MMWR Recomm Rep 55 1-37

[4] Cortese MM(1995)A population-based serologic survey of immunity to tetanus in the United States N Engl J Med 332 761-766

[5] Murphy TV(1996)Seroprevalence of tetanus antibodies among adults older than 65 years Ann Emerg Med 28 18-21

[6] Kretsinger K(2004)Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds Ann Emerg Med 43 305-314

[7] Broder KR(2004)Seroprevalence for tetanus antibodies among immigrants over age 50: comparison to an age matched US born population Ann Emerg Med 44 S126-831

[8] Cortese MM(2002)Seroprevalence of tetanus antibody among HIV infected patients. Poster presentation American College of Emergency Physicians Annual Meeting, Seattle, WA Oct 6, 2002 Ann Emerg Med 40 S29-804

[9] Joyce MP(1999)Vaccination and HIV: a review of the literature Vaccine 18 825-407

[10] Ortega-Sanchez I(1983)Tetanus and diphtheria immunity in an elderly population in Los Angeles County Am J Public Health 73 802-563

[1] Pascual FB(2003)Tetanus surveillance — United States, 1998—2000 MMWR Surveill Summ 52 1-8

[2] McGinley EL(2003)Recommended childhood immunization schedule—United States, 2003 MMWR Morb Mortal Wkly Rep 52 Q1-Q4

[3] Zanardi LR(2006)Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel MMWR Recomm Rep 55 1-37

[4] Cortese MM(1995)A population-based serologic survey of immunity to tetanus in the United States N Engl J Med 332 761-766

[5] Murphy TV(1996)Seroprevalence of tetanus antibodies among adults older than 65 years Ann Emerg Med 28 18-21

[6] Kretsinger K(2004)Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds Ann Emerg Med 43 305-314

[7] Broder KR(2004)Seroprevalence for tetanus antibodies among immigrants over age 50: comparison to an age matched US born population Ann Emerg Med 44 S126-831

[8] Cortese MM(2002)Seroprevalence of tetanus antibody among HIV infected patients. Poster presentation American College of Emergency Physicians Annual Meeting, Seattle, WA Oct 6, 2002 Ann Emerg Med 40 S29-804

[9] Joyce MP(1999)Vaccination and HIV: a review of the literature Vaccine 18 825-407

[10] Ortega-Sanchez I(1983)Tetanus and diphtheria immunity in an elderly population in Los Angeles County Am J Public Health 73 802-563